Current Assets
Short-Term Investments
Bristol-Myers Squibb Short-Term Investments increased by 96.6% to $912M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $907M to $912M. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows a downward trend with a -18.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher levels indicate effective treasury management of excess capital, whereas lower levels may signal cash being deployed into operations or acquisitions.
Detailed definition
These are marketable securities and financial instruments that are expected to be converted into cash within one year. T...
Peer comparison
Large-cap pharmaceutical companies often hold significant short-term investment portfolios to manage working capital cycles.
Metric ID:
short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.95B | $2.12B | $2.99B | $2.6B | $2.48B | $1.29B | $130M | $274M | $358M | $171M | $816M | $340M | $360M | $204M | $513M | $907M | $1B | $776M | $464M | $912M |
| QoQ Change | — | +9.1% | +40.7% | -13.0% | -4.7% | -47.8% | -89.9% | +110.8% | +30.7% | -52.2% | +377.2% | -58.3% | +5.9% | -43.3% | +151.5% | +76.8% | +10.7% | -22.7% | -40.2% | +96.6% |
| YoY Change | — | — | — | — | +27.3% | -39.1% | -95.6% | -89.5% | -85.6% | -86.8% | +527.7% | +24.1% | +0.6% | +19.3% | -37.1% | +166.8% | +178.9% | +280.4% | -9.6% | +0.6% |
Range$130M – $2.99B
CAGR-14.7%
Avg YoY Growth+48.9%
Median YoY Growth+0.6%
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's short-term investments?
- Bristol-Myers Squibb (BMY) reported short-term investments of $912M in Q1 2026.
- How has Bristol-Myers Squibb's short-term investments changed year-over-year?
- Bristol-Myers Squibb's short-term investments increased by 0.6% year-over-year, from $907M to $912M.
- What is the long-term trend for Bristol-Myers Squibb's short-term investments?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's short-term investments has grown at a -18.4% compound annual growth rate (CAGR), from $1.29B to $464M.
- What does short-term investments mean?
- Financial investments that the company expects to turn into cash within one year.